CSO Cokey Nguyen will be joining a panel with fellow cell therapy experts this Thursday at #BIO2024 in San Diego on June 6. Join us to learn about the latest developments and future trends in #allogeneic cell therapies, which are poised to usher in a new wave of innovation.
Atara Biotherapeutics’ Post
More Relevant Posts
-
Scotty Chung-Siu, MPH, a managing analyst at GlobalData , revealed that the #APAC region leads with 1,023 single-country trials, significantly surpassing North America’s 476 trials. “The APAC region’s growing dominance holds potential to revolutionize adoptive cell therapy advancements,” said Chung-Siu. 👉 Learn more about APAC’s role in adoptive cell therapy advancements: https://bit.ly/3z9vRIL #AdoptiveCellTherapy #ClinicalTrials #CAR_T #Immunotherapy #BiotechInnovation #HealthcareAdvancements #ClinicalResearch #OutsourcingInClinicalTrials
To view or add a comment, sign in
-
Are you developing allogeneic cell therapies? How do you guarantee their compliant aseptic manufacturing? To get the answers to those questions, you should attend Michela Castellani-Kleinschroth and Koji Ushioda's speech tomorrow at #ATE24 Phacilitate SKAN #AT #AdvancedTherapiesEurope #CellTherapy #AllogeneicTherapy
We are excited to be at #AdvancedTherapiesEurope next week! On Thursday, our experts Michela Castellani-Kleinschroth and Koji Ushioda will join the "Allogeneic Cell Therapies: Spotlight on Innovations and Potential" discussion. Don't miss their presentation on "Boosting the power of allogeneic cell therapy" where they'll discuss the current status and challenges of allogeneic cell therapy, and offer strategies for compliant aseptic manufacturing! For more information, have a look here: https://lnkd.in/ete3AA2v Any question ahead of the talk? Get in touch here: https://lnkd.in/eJHaiU2e Phacilitate SKAN #AT #AdvancedTherapiesEurope #CellTherapy #AllogeneicTherapy
To view or add a comment, sign in
-
Allogeneic cell therapies are on the rise! Interest in allogeneic cell therapies has been increasing steadily over recent years from our analysis, accounting for ~54% of cell therapy deal volume in the most recent year (~24% deal value). Commercial drivers are fueling investor interest with the potential of allogeneic approaches to revolutionalise patient care options in a greatly expanded population. Key technological barriers, primarily safety concerns in allorejection, graft versus host disease, and neurotoxicity are seeing a surge in novel technologies in clinical development that aim to overcome these hurdles. Read more in our short cell therapy update: https://lnkd.in/eTgRNyWD ft. Samvar Shah Gursharan Batra
What are the current emerging trends in allogeneic cell therapy? Dive into our latest update to learn more about investor interest, technological advancements and the commercial drivers that are transforming the allogeneic cell therapy landscape: https://lnkd.in/eTgRNyWD #SyneosHealth ft. Samvar Shah, Harry Bickerstaffe, Gursharan Batra
To view or add a comment, sign in
-
What are the current emerging trends in allogeneic cell therapy? Dive into our latest update to learn more about investor interest, technological advancements and the commercial drivers that are transforming the allogeneic cell therapy landscape: https://ow.ly/ba7s30sFboq #SyneosHealth ft. Samvar Shah, Harry Bickerstaffe, Gursharan Batra
To view or add a comment, sign in
-
Optimizing and containing costs for autologous cell therapies takes a lot of hard work and resources. Let us equip you with the insights and knowledge to make it happen. Download our infographic to get the full picture. https://lnkd.in/eD9BgwuR #autologouscelltherapy #celltherapy #cellandgenetherapy #celltherapymanufacturing
To view or add a comment, sign in
-
Optimizing and containing costs for autologous cell therapies takes a lot of hard work and resources. Let us equip you with the insights and knowledge to make it happen. Download our infographic to get the full picture. https://lnkd.in/eD9BgwuR #autologouscelltherapy #celltherapy #cellandgenetherapy #celltherapymanufacturing
DOWNLOAD: COGs process economics for autologous cell therapy
cytiva.link
To view or add a comment, sign in
-
What are the current emerging trends in allogeneic cell therapy? Dive into our latest update to learn more about investor interest, technological advancements and the commercial drivers that are transforming the allogeneic cell therapy landscape: https://lnkd.in/eTgRNyWD #SyneosHealth ft. Samvar Shah, Harry Bickerstaffe, Gursharan Batra
To view or add a comment, sign in
-
Join us on Tuesday, September 10 at 1 PM ET for a webinar where we’ll be discussing the advantages of negative selection for cell isolation. Learn more about the benefits of using untouched cells in cell therapy and hear from our expert panel on why Akadeum is leading the charge toward this important approach. https://hubs.li/Q02MdSRL0 #thepositivesofnegativeselection #bettertcells #cellisolation #negativeselectionatscale
To view or add a comment, sign in
-
Sadik Kassim shares what motivates him to do the work that has advanced cell therapy development to a point that seemed impossible only a decade ago. Watch the series finale of 'Pioneers and visionaries of cell therapy': https://lnkd.in/dBhZWSzq #celltherapy #cellandgenetherapy #genomicmedicine #CART
To view or add a comment, sign in
-
Sadik Kassim shares what motivates him to do the work that has advanced cell therapy development to a point that seemed impossible only a decade ago. Watch the series finale of 'Pioneers and visionaries of cell therapy': https://lnkd.in/gfNKmc_J #celltherapy #cellandgenetherapy #genomicmedicine #CART
To view or add a comment, sign in
37,096 followers